Not only do digestive diseases account for 13% of all deaths in the UK but functional gastrointestinal disorders impact the lives of 11% of the population.

One particular area of concern within gastrointestinal medicine is constipation – something 10% of children around the world suffer from at some point in their lives.

Furthermore, constipation becomes chronic in 30% of these children, affecting their well-being and that of their parents and carers. In England alone, 27,500 children are referred to hospital each year.

Looking for innovative solutions to this health problem, Dr Luca Marciani, Associate Professor in GI MRI (Gastrointestinal Magnetic Resonance Imaging) at the University of Nottingham, presented an impact case study during the Nottingham BRC First Anniversary Conference.

Dr Marciani showcased the work of the MAGIC project - MAGnetic resonance Imaging of gastrointestinal transit in paediatric Constipation - which is research funded by an NIHR Invention for Innovation (i4i) award.

Management of children with constipation is difficult and based mostly on symptom reports. An objective measure of the time food takes to travel through the gut (‘gut transit time’) could help hospital doctors make a more informed, early selection of the right therapy, particularly when medical history is unclear.

This could speed up treatment, improve children’s and parents’ satisfaction and has the potential to save the NHS money.

However, as Dr Marciani explained, gut transit time is very often not tested since current X-ray methods are unable to define the colon anatomy well, due to overlapping colon loops. X-rays also provide a radiation dose, which is not suitable for young patients.

Together, MAGIC researchers have co-designed and co-produced a new patented method of measuring gut transit time, similar to the X-ray method but without the need for radiation exposure. It involves new mini-capsules, only a few millimetres long, which are easy for a child or young person to swallow.

The capsules do not dissolve in the body but instead travel through the gut and can be imaged at a later time using a quick, straight-forward MRI scan. From the images, one can determine how far the mini-capsules have travelled, which provides a measure of gut transit time.

MRI is non-invasive and can be used safely in young patients time and time again if necessary, to follow up response to treatment. The type of MRI required is widely available and the research teams’ mini-capsules can be used in hospitals everywhere.

The MAGIC project team is currently running the feasibility clinical study in young patients and healthy controls. 

In May 2019, new funding was announced to expand this research. A second NIHR i4i grant of £1.2 million is funding the second phase of the clinical trial; MAGIC2.

This will be a larger study in 436 young patients with constipation to show that using mini-capsules in standard clinical practice can improve the success of available treatments. It will also develop new and more cost-effective ways to mass-produce the mini-capsules and create software capable of detecting the mini-capsules automatically.

The MAGIC team includes the Nottingham University Hospitals’ (NUH's) Young Person Advisory Group (YPAG), parents, patient and public involvement specialists, scientists, and clinicians. Also involved are three UK small-medium enterprise (SME) companies that design medical devices (Renfrew Group International), medical image analysis software (Motilent), and manufacture medical devices (JEB Technologies).

Website by Volute